MXPA01008502A - Proceso para la produccion de paroxetina. - Google Patents

Proceso para la produccion de paroxetina.

Info

Publication number
MXPA01008502A
MXPA01008502A MXPA01008502A MXPA01008502A MXPA01008502A MX PA01008502 A MXPA01008502 A MX PA01008502A MX PA01008502 A MXPA01008502 A MX PA01008502A MX PA01008502 A MXPA01008502 A MX PA01008502A MX PA01008502 A MXPA01008502 A MX PA01008502A
Authority
MX
Mexico
Prior art keywords
paroxetine
production
paroxetin
sesamol
derivatisation
Prior art date
Application number
MXPA01008502A
Other languages
English (en)
Spanish (es)
Inventor
Renzo Rossi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Publication of MXPA01008502A publication Critical patent/MXPA01008502A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA01008502A 1999-02-23 2000-02-22 Proceso para la produccion de paroxetina. MXPA01008502A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000364A IT1308629B1 (it) 1999-02-23 1999-02-23 Processo per la produzione di paroxetina.
PCT/EP2000/001430 WO2000050422A1 (en) 1999-02-23 2000-02-22 Process for the production of paroxetine

Publications (1)

Publication Number Publication Date
MXPA01008502A true MXPA01008502A (es) 2003-06-06

Family

ID=11382007

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01008502A MXPA01008502A (es) 1999-02-23 2000-02-22 Proceso para la produccion de paroxetina.

Country Status (28)

Country Link
US (1) US6583287B1 (US20030204114A1-20031030-C00018.png)
EP (1) EP1153023B1 (US20030204114A1-20031030-C00018.png)
JP (1) JP2002537394A (US20030204114A1-20031030-C00018.png)
KR (1) KR20010102366A (US20030204114A1-20031030-C00018.png)
CN (1) CN1161353C (US20030204114A1-20031030-C00018.png)
AT (1) ATE238295T1 (US20030204114A1-20031030-C00018.png)
AU (1) AU759441B2 (US20030204114A1-20031030-C00018.png)
BR (1) BR0008220A (US20030204114A1-20031030-C00018.png)
CA (1) CA2361758A1 (US20030204114A1-20031030-C00018.png)
CZ (1) CZ20012997A3 (US20030204114A1-20031030-C00018.png)
DE (1) DE60002303T2 (US20030204114A1-20031030-C00018.png)
DK (1) DK1153023T3 (US20030204114A1-20031030-C00018.png)
ES (1) ES2195876T3 (US20030204114A1-20031030-C00018.png)
HK (1) HK1040516B (US20030204114A1-20031030-C00018.png)
HR (1) HRP20010608A2 (US20030204114A1-20031030-C00018.png)
HU (1) HUP0105482A3 (US20030204114A1-20031030-C00018.png)
IL (1) IL144883A (US20030204114A1-20031030-C00018.png)
IT (1) IT1308629B1 (US20030204114A1-20031030-C00018.png)
MX (1) MXPA01008502A (US20030204114A1-20031030-C00018.png)
NO (1) NO319724B1 (US20030204114A1-20031030-C00018.png)
PL (1) PL349358A1 (US20030204114A1-20031030-C00018.png)
PT (1) PT1153023E (US20030204114A1-20031030-C00018.png)
RU (1) RU2242473C2 (US20030204114A1-20031030-C00018.png)
SK (1) SK12042001A3 (US20030204114A1-20031030-C00018.png)
TR (1) TR200102441T2 (US20030204114A1-20031030-C00018.png)
TW (1) TWI221473B (US20030204114A1-20031030-C00018.png)
WO (1) WO2000050422A1 (US20030204114A1-20031030-C00018.png)
YU (1) YU60801A (US20030204114A1-20031030-C00018.png)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005001873T2 (de) * 2004-03-03 2008-04-24 Chemi S.P.A., Cinisello Balsamo Amorphe 3-Pyridyl-1-Hydroxyethyliden-1,1-Bisphosphonsäure Mononatriumsalz und Verfahren zu deren Herstellung
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
RU2616610C2 (ru) * 2012-01-31 2017-04-18 Эйсай Ар Энд Ди Менеджмент Ко., Лтд. Производное пароксетина
CN106831736A (zh) * 2017-02-15 2017-06-13 浙江华海药业股份有限公司 一种制备帕罗西汀杂质的方法
CN112521377A (zh) * 2020-11-26 2021-03-19 北京福元医药股份有限公司 一种盐酸帕罗西汀的连续化制备方法
CN115260153B (zh) * 2022-07-21 2023-10-27 威尚(上海)生物医药有限公司 一种6取代手性纯二氟哌啶喹唑啉衍生物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0757758B2 (ja) 1988-10-24 1995-06-21 高砂香料工業株式会社 ルテニウム―ホスフィン錯体
DK715988D0 (da) * 1988-12-22 1988-12-22 Ferrosan As Etherifikation og dealkylering af piperidin-derivater samt intermediater
US5233084A (en) 1989-06-22 1993-08-03 Monsanto Company Method for preparing α-arylpropionic acids
FR2651152B1 (fr) * 1989-08-23 1991-11-29 Elf Aquitaine Perfectionnement a la preparation de catalyseurs chiraux a base de complexes du ruthenium et du phosphore.
GB9209687D0 (en) 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
DE4422672A1 (de) * 1994-06-30 1996-01-04 Hoechst Ag Halogenierte Biphenyl-2,2'-diyl-bis-diphenylphosphine, ihre Herstellung und ihre Verwendung
JPH11505229A (ja) * 1995-05-17 1999-05-18 ノボ ノルディスク アクティーゼルスカブ 4−アリール−ピペリジン誘導体を製造する方法
HU221921B1 (hu) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzil-piperidin- és tetrahidropiridinszármazékok és eljárás azok előállítására
EP0983239A1 (en) * 1997-05-06 2000-03-08 Novo Nordisk A/S Novel heterocyclic compounds
DE69820205T2 (de) * 1997-05-20 2004-09-30 Firmenich S.A. Ruthenium-katalysatoren und ihre verwendung zur asymmetrischen hydrierung von substraten mit schwacher koordination

Also Published As

Publication number Publication date
AU3158300A (en) 2000-09-14
DK1153023T3 (da) 2003-08-11
ATE238295T1 (de) 2003-05-15
KR20010102366A (ko) 2001-11-15
HK1040516A1 (en) 2002-06-14
NO319724B1 (no) 2005-09-05
EP1153023B1 (en) 2003-04-23
PT1153023E (pt) 2003-09-30
HUP0105482A2 (en) 2002-08-28
WO2000050422A1 (en) 2000-08-31
YU60801A (sh) 2005-07-19
RU2242473C2 (ru) 2004-12-20
IT1308629B1 (it) 2002-01-09
CN1161353C (zh) 2004-08-11
EP1153023A1 (en) 2001-11-14
TR200102441T2 (tr) 2002-01-21
TWI221473B (en) 2004-10-01
DE60002303D1 (de) 2003-05-28
CZ20012997A3 (cs) 2001-11-14
NO20014078D0 (no) 2001-08-22
CA2361758A1 (en) 2000-08-31
US6583287B1 (en) 2003-06-24
CN1341113A (zh) 2002-03-20
HK1040516B (zh) 2003-10-31
JP2002537394A (ja) 2002-11-05
NO20014078L (no) 2001-10-18
DE60002303T2 (de) 2004-04-01
BR0008220A (pt) 2001-11-06
PL349358A1 (en) 2002-07-15
SK12042001A3 (sk) 2001-12-03
ITMI990364A1 (it) 2000-08-23
HRP20010608A2 (en) 2002-08-31
IL144883A (en) 2004-12-15
IL144883A0 (en) 2002-06-30
ES2195876T3 (es) 2003-12-16
AU759441B2 (en) 2003-04-17
HUP0105482A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
PL378168A1 (pl) Dihydropterydynony, sposoby ich wytwarzania i ich zastosowanie w postaci leków
RS20050173A (en) Novel carboxamide compounds having an mch-antagonistic effect,medicaments containing said compounds,and methods for the production thereof
ZA962747B (en) Novel intermediates and process for the manufacturNovel intermediates and process for the manufacture of camptothecin derivatives (CPT-11) and relatede of camptothecin derivatives (CPT-11) and related compounds. compounds.
UA49796C2 (uk) Ангідрат пароксетин гідрохлориду, спосіб його одержання, сольвати пароксетин гідрохлориду, спосіб їх одержання, спосіб лікування та/або профілактики та фармацевтична композиція
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
MY127793A (en) Novel form of s-omeprazole.
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
MY150088A (en) Immunosuppressant compounds and compositions
TW200500368A (en) Process to tetrahydrotriazolopyrazines and intermediates
MXPA01008502A (es) Proceso para la produccion de paroxetina.
DE60321452D1 (de) Als modulatoren der chemokinrezeptoraktivität geeignete piperidinderivate
UA85428C2 (ru) Способ получения с-2, с-3 замещенных n-алкилированных индолов, а также промежуточные соединения и способы их получения
MXPA03010960A (es) Proceso para la produccion de fexofenadina derivado de piperidina.
MX2008000821A (es) Nuevos derivados de piperidina.
WO2005040129A3 (en) Ccr3 receptor antagonists
ATE383343T1 (de) Imidazolderivate verwendbar als histamin h3 rezeptorliganden
WO2003106440A3 (en) PROCESS FOR THE SYNTHESIS OF A BENZAMIDE DERIVATIVE
RS20060263A (en) Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
MXPA05009153A (es) Proceso para preparar 2-metilpirrolidina y enantiomeros especificos de la misma.
IL174957A0 (en) Method for producing n-substituted 3??-aminonortropanes
DE50007410D1 (de) Verfahren zur herstellung von 1,3-disubstituierten 2-nitroguanidinen
ES2117934A1 (es) Tetrahidropiridinas (0 4-hidroxipiperidinas) alquilazoles.
SU1563187A1 (ru) 1-(2-этоксиэтил)-4-оксипиперидин в качестве промежуточного соединения в синтезе гидрохлоридов 1-(2-этоксиэтил)-4-ацилоксипиперидинов, обладающих местно-анестезирующей активностью

Legal Events

Date Code Title Description
FG Grant or registration